Profiel
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Eerdere bekende functies van Stephane Depil
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 01-02-2019 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Chief Executive Officer | - |
| Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Opleiding van Stephane Depil
| Université de Lille III | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Health Technology |
| Centre Léon Bérard Lyon et Rhône-Alpes |
